Chronic pancreatitis is a multifactorial, fibroinflammatory syndrome in which repetitive
episodes of pancreatic inflammation lead to extensive fibrotic tissue replacement, resulting …

Background: Pancreatic exocrine insufficiency (PEI) is characterized by inadequate
production, insufficient secretion, and/or inactivation of pancreatic enzymes, resulting in …

Objectives Pancreatic exocrine insufficiency (PEI) is a common complication in patients with
chronic pancreatitis (CP), leading to increased morbidity and mortality if not treated …

Introduction Despite evidence-based guidelines, exocrine pancreatic insufficiency is
frequently underdiagnosed and undertreated in patients with chronic pancreatitis. Therefore …

Increasing evidence supports the relevance of PEI management by dietary advice and
appropriate PERT. Well designed and powered randomized, placebo-controlled clinical …

Holistic management of pancreatitis means that gastroenterologists in the 21st Century
should think beyond improving in-hospital outcomes of pancreatitis alone. In particular, there …

Pancreatic enzyme replacement therapy (PERT) has been recommended as the preferred
method for pancreatic exocrine insufficiency caused by chronic pancreatitis (CP). However …

Background The major risk factors for atherosclerotic cardiovascular disease differ by race
or ethnicity but have largely been defined using populations of European ancestry. Despite …

The high incidence and significant impact of diabetes on the morbidity and mortality of
patients with chronic pancreatitis highlights the urgent need for clinically applicable models …

Pancreatic exocrine insufficiency (PEI) is highly prevalent in patients with pancreatic cancer,
and has substantial implications for quality of life and survival. Post resection, PEI is …